Neonatal Mortality
2
Pipeline Programs
3
Companies
3
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
2
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
Human BioSciencesWV - Martinsburg
1 program1
Newborn skin cleansing with 0.25% chlorhexidine solutionPhase 31 trial
Active Trials
Pediatrix TherapeuticsChina - Shanghai
1 programFactors Associated With Mortality in NeonatesN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
March BiosciencesNeonatal kit
Human BioSciencesNewborn skin cleansing with 0.25% chlorhexidine solution
Pediatrix TherapeuticsFactors Associated With Mortality in Neonates
Clinical Trials (3)
Total enrollment: 26,163 patients across 3 trials
Newborn Kit to Save Lives in Pakistan
Start: Apr 2014Est. completion: Feb 20178,518 patients
Phase 3Completed
Community Trial of Newborn Skin and Umbilical Cord Cleansing on Neonatal Mortality in Nepal
Start: Oct 2002Est. completion: Jan 200617,000 patients
Phase 3Completed
Factors Associated With Mortality in Neonates
Start: Sep 2010Est. completion: Oct 2012645 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 late-stage (Phase 3) programs, potential near-term approvals
3 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.